Study analysis · Journal of Bone and Mineral Research · 2024
Your hip bone density could be predicting your next fracture—10x higher risk if you're in the bottom 20%.
Women with weaker hip bones are up to 10 times more likely to break their hip than those with strong ones—even if they're the same age.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
In simple terms
This study found that women with weaker bones (lower BMD) were more likely to break a bone over time — but it didn’t change anyone’s bones to test if making them stronger would help. So we know weak bones are linked to more breaks, but we don’t know for sure that fixing the weakness stops the breaks.
What’s the bottom line?
This study looked at thousands of older women who didn't take osteoporosis drugs to see if their bone strength (measured by BMD) could predict if they'd break a bone.
How strong is this study?
This is one of the best studies of its kind because it combined data from 25 big, well-run experiments with over 46,000 women. The researchers were super careful to measure bones and breaks the same way everywhere. But it still only looked at women who were already in trials — so we can’t be sure it applies to everyone.
40 / 100
- COI disclosure+40/40
- Data availabilitydata not shared
- Code availabilitycode not shared
25 / 100
- Randomizationrandomization unclear
- Blindingblinding unclear
- Control groupno control group
- Sample size (n=46666)+20/20
- Follow-upno follow-up reported
100 / 100
77 / 100
- P-values+15/15
- Effect size+20/20
- Confidence intervals+15/15
- Pre-registrationnot pre-registered
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 556 / 100
Probability of being correct
The highest quality evidence. Systematic reviews and meta-analyses that pool randomized controlled trials, giving the most reliable summary of experimental evidence.
This design cannot establish causation — the findings describe an association, not a cause. This study analyzes placebo groups from RCTs to assess associations between baseline BMD and fracture risk. It does not test any intervention, so it cannot establish causation. It only observes pre-existing relationships in untreated populations.
No Conflicts
No conflicts of interest identified
No conflicts of interest were disclosed, and the study appears to be independently conducted using pooled data from multiple randomized trials.
Funders
Conflict Details
Foundation for the National Institutes of Health (FNIH): Provided funding and infrastructure for the SABRE project that supplied the pooled IPD
American Society for Bone and Mineral Research (ASBMR): Collaborated with FNIH to support the SABRE project
Independent Analysis Safeguards
- Analysis used pooled placebo data from 25 independent RCTs
- Statistical methods applied consistently across studies
- Adjustments made for study, age, and race to control for confounding
- Data conversion methods standardized using published equations
The study is a meta-analysis of existing placebo groups from prior trials; no industry sponsors are mentioned. The FNIH and ASBMR are public-private partnerships with no indication of commercial influence on study conduct or reporting.
Key takeaways
- 01
Women with the weakest hip bones had 10 times more hip fractures than those with the strongest bones.
- 02
Every time hip bone density dropped by one standard deviation, hip fracture risk went up 2.27 times.
- 03
Yes — this means bone density is a very strong warning sign: if your hip bones are weak, you're much more likely to break a hip, even if you're the same age as someone with stronger bones.
Surprising findings
- Lumbar spine BMD had no significant association with hip fracture risk (RR=1.01 per SD decrease), despite being the most commonly tested site.Most people and clinics focus on spine scans because they're easier to do—but this massive study proves they're useless for predicting the most dangerous fractures.
- Hip and femoral neck BMD were nearly identical in predictive power, despite being different anatomical sites.Many assumed femoral neck (a narrower, more fragile part) would be a better predictor—but the total hip (larger, more stable area) performed just as well.
Practical takeaways
If you're a postmenopausal woman, ask your doctor for a hip BMD scan—not just a spine scan—to accurately assess your fracture risk.
This study only applies to postmenopausal women; results may not translate to men, younger women, or non-White populations due to limited diversity.
high confidenceIf your hip BMD is in the lowest quintile, prioritize fall prevention: remove rugs, install grab bars, and consider vitamin D and strength training.
BMD is just one factor—balance, muscle strength, and medications also matter. Don't panic if your score is low; act strategically.
high confidenceWhy this study matters
Hip BMD = Hip Fracture Predictor
Each standard deviation drop in total hip bone mineral density (BMD) was linked to a 2.27-fold increase in hip fracture risk. This relationship held even after adjusting for age and race, and was consistent across 46,666 postmenopausal women from 25 clinical trials.
This isn't just correlation—it's a powerful, quantifiable warning sign. If you know your hip BMD, you can estimate your fracture risk with surprising accuracy, which could change how you think about bone health.
Spine BMD Doesn't Predict Hip Fractures
Lumbar spine BMD strongly predicts vertebral fractures (1.56x risk per SD drop) but showed no significant link to hip or non-vertebral fractures (RR=1.01). This means your spine scan alone won't tell you if you're at risk for a broken hip.
Most people think 'osteoporosis = spine scan'—but this study proves that’s misleading. Your spine density is useless for predicting the most dangerous fractures.
10x Risk Jump Between Top and Bottom Quintiles
Women in the lowest 20% of hip BMD had a 10-fold higher risk of hip fracture compared to those in the top 20%. This isn't a linear trend—it's a cliff edge.
It’s not just 'a little riskier'—it's life-altering. This shows bone density isn't a sliding scale; it's a tipping point for catastrophic injury.
Want the whole report?
Detailed mode opens the full scientific breakdown — every score component, the methodology, conflicts of interest, the evidence analysis behind each claim, and the raw study data.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
This study looked at thousands of older women who didn't take osteoporosis drugs to see if their bone strength (measured by BMD) could predict if they'd break a bone.
Research results
Women with the weakest hip bones had 10 times more hip fractures than those with the strongest bones. Every time hip bone density dropped by one standard deviation, hip fracture risk went up 2.27 times.
What this means - more context
Yes — this means bone density is a very strong warning sign: if your hip bones are weak, you're much more likely to break a hip, even if you're the same age as someone with stronger bones.
This study assesses whether baseline bone mineral density (BMD) strongly predicts fracture risk in postmenopausal women to support using changes in total hip BMD as a surrogate endpoint for fracture reduction in osteoporosis drug trials.
Using individual patient data from 46,666 placebo participants across 25 RCTs, the study found that lower baseline total hip and femoral neck BMD are strongly associated with increased hip and clinical fracture risk (e.g., 2.27-fold higher hip fracture risk per SD decrease), while lumbar spine BMD predicts only vertebral fractures. Fracture risk increased tenfold from highest to lowest hip BMD quintiles, confirming a graded, dose-dependent relationship.
Methods Used
Individual patient data from 25 randomized controlled trials (RCTs) were pooled; baseline BMD (total hip, femoral neck, lumbar spine) was harmonized across DXA devices using standardized conversions. Fracture risk was analyzed using logistic and proportional hazards models per standard deviation decrease in BMD, adjusted for age, race, and study, with 250,662 total person-years of follow-up.
Main Finding
Each standard deviation decrease in total hip BMD was associated with a 2.27-fold higher risk of hip fracture and a 1.35-fold higher risk of all clinical fractures; femoral neck BMD showed similar predictive strength, while lumbar spine BMD predicted only vertebral fractures (RR=1.56/SD) with no significant association to hip or non-vertebral fractures.
Confidence Level
High confidence due to large sample size (46,666 participants), harmonized BMD and fracture definitions across 25 rigorously conducted RCTs, adjustment for key confounders, and consistent effect sizes across analyses.
Study Flags
Red Flags
- •Predominantly female participants (99.3%), limiting generalizability to men
- •Limited racial diversity (mostly White participants)
- •Participants were from clinical trials with high-risk selection bias
No biological mechanisms were identified in this study. This may be an epidemiological, observational, or survey-based study that reports associations rather than proposing causal biological pathways.
Surprising Findings
Lumbar spine BMD had no significant association with hip fracture risk (RR=1.01 per SD decrease), despite being the most commonly tested site.
Most people and clinics focus on spine scans because they're easier to do—but this massive study proves they're useless for predicting the most dangerous fractures.
Practical Takeaways
If you're a postmenopausal woman, ask your doctor for a hip BMD scan—not just a spine scan—to accurately assess your fracture risk.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 556 / 100
Probability of being correct
The highest quality evidence. Systematic reviews and meta-analyses that pool randomized controlled trials, giving the most reliable summary of experimental evidence.
Human Meta-Analysis
Subject
Moderate probability
on the GRADE evidence scale
This study found that women with weaker bones (lower BMD) were more likely to break a bone over time — but it didn’t change anyone’s bones to test if making them stronger would help. So we know weak bones are linked to more breaks, but we don’t know for sure that fixing the weakness stops the breaks.
No conflicts of interest were detected in this study. No score impact.
Strengths
- Large sample size (46,666 participants)
- Individual patient data from 25 high-quality RCTs
- Harmonized BMD measurements across devices
Weaknesses
- No male participants in majority
- Limited racial diversity
- All participants were from clinical trial populations (not general population)
Methodology
Evidence Keywords
Statistical Reporting
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
This study looked at thousands of older women who didn't take osteoporosis drugs to see if their bone strength (measured by BMD) could predict if they'd break a bone.
Research results
Women with the weakest hip bones had 10 times more hip fractures than those with the strongest bones. Every time hip bone density dropped by one standard deviation, hip fracture risk went up 2.27 times.
What this means - more context
Yes — this means bone density is a very strong warning sign: if your hip bones are weak, you're much more likely to break a hip, even if you're the same age as someone with stronger bones.
This study assesses whether baseline bone mineral density (BMD) strongly predicts fracture risk in postmenopausal women to support using changes in total hip BMD as a surrogate endpoint for fracture reduction in osteoporosis drug trials.
Using individual patient data from 46,666 placebo participants across 25 RCTs, the study found that lower baseline total hip and femoral neck BMD are strongly associated with increased hip and clinical fracture risk (e.g., 2.27-fold higher hip fracture risk per SD decrease), while lumbar spine BMD predicts only vertebral fractures. Fracture risk increased tenfold from highest to lowest hip BMD quintiles, confirming a graded, dose-dependent relationship.
Methods Used
Individual patient data from 25 randomized controlled trials (RCTs) were pooled; baseline BMD (total hip, femoral neck, lumbar spine) was harmonized across DXA devices using standardized conversions. Fracture risk was analyzed using logistic and proportional hazards models per standard deviation decrease in BMD, adjusted for age, race, and study, with 250,662 total person-years of follow-up.
Main Finding
Each standard deviation decrease in total hip BMD was associated with a 2.27-fold higher risk of hip fracture and a 1.35-fold higher risk of all clinical fractures; femoral neck BMD showed similar predictive strength, while lumbar spine BMD predicted only vertebral fractures (RR=1.56/SD) with no significant association to hip or non-vertebral fractures.
Confidence Level
High confidence due to large sample size (46,666 participants), harmonized BMD and fracture definitions across 25 rigorously conducted RCTs, adjustment for key confounders, and consistent effect sizes across analyses.
Study Flags
Red Flags
- •Predominantly female participants (99.3%), limiting generalizability to men
- •Limited racial diversity (mostly White participants)
- •Participants were from clinical trials with high-risk selection bias
No biological mechanisms were identified in this study. This may be an epidemiological, observational, or survey-based study that reports associations rather than proposing causal biological pathways.
Surprising Findings
Lumbar spine BMD had no significant association with hip fracture risk (RR=1.01 per SD decrease), despite being the most commonly tested site.
Most people and clinics focus on spine scans because they're easier to do—but this massive study proves they're useless for predicting the most dangerous fractures.
Practical Takeaways
If you're a postmenopausal woman, ask your doctor for a hip BMD scan—not just a spine scan—to accurately assess your fracture risk.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 556 / 100
Probability of being correct
The highest quality evidence. Systematic reviews and meta-analyses that pool randomized controlled trials, giving the most reliable summary of experimental evidence.
Human Meta-Analysis
Subject
Moderate probability
on the GRADE evidence scale
This study found that women with weaker bones (lower BMD) were more likely to break a bone over time — but it didn’t change anyone’s bones to test if making them stronger would help. So we know weak bones are linked to more breaks, but we don’t know for sure that fixing the weakness stops the breaks.
No conflicts of interest were detected in this study. No score impact.
Strengths
- Large sample size (46,666 participants)
- Individual patient data from 25 high-quality RCTs
- Harmonized BMD measurements across devices
Weaknesses
- No male participants in majority
- Limited racial diversity
- All participants were from clinical trial populations (not general population)
Methodology
Evidence Keywords
Statistical Reporting
Scoring
How strong is this study?
This is one of the best studies of its kind because it combined data from 25 big, well-run experiments with over 46,000 women. The researchers were super careful to measure bones and breaks the same way everywhere. But it still only looked at women who were already in trials — so we can’t be sure it applies to everyone.
40 / 100
- COI disclosure+40/40
- Data availabilitydata not shared
- Code availabilitycode not shared
25 / 100
- Randomizationrandomization unclear
- Blindingblinding unclear
- Control groupno control group
- Sample size (n=46666)+20/20
- Follow-upno follow-up reported
100 / 100
77 / 100
- P-values+15/15
- Effect size+20/20
- Confidence intervals+15/15
- Pre-registrationnot pre-registered
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 556 / 100
Probability of being correct
The highest quality evidence. Systematic reviews and meta-analyses that pool randomized controlled trials, giving the most reliable summary of experimental evidence.
This design cannot establish causation — the findings describe an association, not a cause. This study analyzes placebo groups from RCTs to assess associations between baseline BMD and fracture risk. It does not test any intervention, so it cannot establish causation. It only observes pre-existing relationships in untreated populations.
No Conflicts
No conflicts of interest identified
No conflicts of interest were disclosed, and the study appears to be independently conducted using pooled data from multiple randomized trials.
Funders
Conflict Details
Foundation for the National Institutes of Health (FNIH): Provided funding and infrastructure for the SABRE project that supplied the pooled IPD
American Society for Bone and Mineral Research (ASBMR): Collaborated with FNIH to support the SABRE project
Independent Analysis Safeguards
- Analysis used pooled placebo data from 25 independent RCTs
- Statistical methods applied consistently across studies
- Adjustments made for study, age, and race to control for confounding
- Data conversion methods standardized using published equations
The study is a meta-analysis of existing placebo groups from prior trials; no industry sponsors are mentioned. The FNIH and ASBMR are public-private partnerships with no indication of commercial influence on study conduct or reporting.
Standing
Who’s using this study?
The videos and claims on this site that lean on this study, and the researchers who wrote it.
1 video from Dr Brad Stanfield cite this study, drawing 1 claim from it.
- Very strong evidence
Randomized or controlled trials support this claim, alongside consistent supporting evidence.
Evidence
Authored by
9 researchersIf this is your work, this is how we attribute it on Fit Body Science. Marian Schini is listed as the lead author.